ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a blank-check company focused on the life sciences and biotechnology sector, sponsored by ARYA Sciences Holdings IV, an affiliate of Perceptive Advisors, a healthcare-dedicated investment firm with a long track record in the sector. The company completed its initial public offering in 2021 and filed an 8-K with the SEC on March 2, 2021. ARYD is the fourth vehicle in Perceptive's ARYA Sciences SPAC series, each targeting innovation-stage healthcare and biopharmaceutical businesses. Sign up at SpacDesk for full filing history, deal timelines, and sponsor analytics on ARYD and the broader ARYA Sciences franchise.